llm_output,best_matching_ground_truth,best_evaluation,best_score
Selective Serotonin Reuptake Inhibitors (SSRIs) widely used for Depression,Monoamine oxidase inhibitors Eligible for Patients who do not respond to other treatments,"Score: 0.60
The LLM output is partly correct as SSRIs are indeed widely used for depression, but it is not a direct match for the ground truth statement about monoamine oxidase inhibitors being eligible for patients who do not respond to other treatments.",0.6
ECT Highly effective for Depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75
The LLM output is largely correct but lacks the nuance of the ground truth statement by not specifying that ECT is effective in some situations during the acute phase of depression.",0.75
"Anxious Depression more common than nonanxious depression in African American group, Hispanics, Primary Care Patients, Unemployed, Married then Divorced/Widowed, Less Education, Public insurance, Lower-income","Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.50
The LLM output is not highly correct because it does not directly relate to the ground truth statement about problem-solving therapy for preventing depression among the elderly and treating mild depressive symptoms in primary care.",0.5
Ketamine Highly effective for treatment-resistant depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.75
The LLM output is mostly correct but oversimplified compared to the ground truth statement because it focuses on treatment-resistant depression rather than specifying both unipolar and bipolar depression.",0.75
Anxious Depression side effects low remission rates,Depression Side effect Mortality,"Score: 0.50
The LLM output partially captures the concept of depression and side effects, but does not mention mortality.",0.5
Anxious Depression side effects low response rates,Nefazodone Side effects Rare cases of clinical idiosyncratic hepatotoxicity,"Score: 0.75
The LLM output differs significantly from the ground truth in terms of both the information provided and relevance, resulting in a lower correctness score.",0.75
Anxious Depression side effects low response rates,"Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 0.75
The LLM output is mostly incorrect as it does not accurately reflect the side effects of ketamine, but it does mention some mental health side effects which are partially relevant.",0.75
SSRIs More commonly used Depression,SSRIs Treat Acute phase of depression,"Score: 0.75
The LLM output is mostly correct in identifying SSRIs as commonly used for depression, but it misses the specific detail that they are used to treat the acute phase of depression.",0.75
Anxious Depression side effects low remission rates,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is somewhat relevant but lacks the direct correlation between depression and slower response to treatment mentioned in the ground truth.",0.75
Physical exercise treats Depression,Physical Exercise Finding an adjunct to other Anti-depressive treatments,"Score: 0.75
The LLM output is mostly correct in summarizing the relationship between physical exercise and depression, but it oversimplifies by stating that physical exercise ""treats"" depression rather than being an adjunct to other treatments.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) synonym Gold-standard treatment,Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.50
The LLM output is partially correct as it mentions SSRIs, which are a type of antidepressant, but it is not completely accurate as it refers to them as the gold-standard treatment instead of norepinephrine reuptake inhibitors.",0.5
Monoamine Oxidase Inhibitors (MAOIs) Comparable to Tricyclic antidepressants (TCAs) for treating Depression with atypical features,Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.90
The LLM output is highly accurate as it correctly conveys that MAOIs and TCAs have comparable efficacy for treating depression with atypical features.",0.9
Tricyclic Antidepressants (TCAs) More effective than Selective Serotonin Reuptake Inhibitors (SSRIs) in treating hospitalized patients with severe Major Depressive Disorder,Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output is mostly correct as it discusses the effectiveness of TCAs in comparison to SSRIs for treating severe major depressive disorder, but it doesn't directly address the Ground Truth statement about MAOIs and TCAs having the same efficacy.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) Recommended as the first-line treatment for patients with Major Depression,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output is partially correct as SSRIs are indeed recommended as a first-line treatment for Major Depression, but it does not fully align with the ground truth statement regarding the use of marital and family therapy for severe forms of depression.",0.75
"MAOIs Specific efficacy in treating depression with atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.95
The LLM output is almost identical to the ground truth statement, accurately reflecting the specific efficacy of MAOIs in treating depression with atypical features.",0.95
ECT Properties Most effective somatic therapy for depression in specific situations,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.90
The LLM output is mostly correct but introduces some specificity about ECT being the most effective somatic therapy, which is not explicitly stated in the ground truth.",0.9
Depression Definition a prevalent psychiatric disorder that often leads to poor quality of life and impaired functioning,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output provides a generally correct definition of depression, but does not directly address the statement about slower response to treatment, resulting in a slightly lower overall correctness score.",0.75
Psychoeducation and physical exercise Treats All Depression,Physical Exercise Finding an adjunct to other Anti-depressive treatments,"Score: 0.75
The LLM output is mostly correct as it emphasizes the importance of psychoeducation and physical exercise in treating depression, but it oversimplifies by stating it treats ""all depression"" instead of as an adjunct to other treatments.",0.75
"Ketamine Side effects Common adverse effects include dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 1.00
The LLM output is exactly the same as the ground truth statement, demonstrating perfect accuracy in reproducing the information.",1.0
"Mirtazapine, Escitalopram, Venlafaxine, Sertraline more effective than Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies specific antidepressants as being more effective than others, but does not directly relate to the ground truth regarding the effectiveness of repetitive transcranial magnetic stimulation.",0.75
Reboxetine less effective than all the other antidepressants tested,Transcranial direct current stimulation Results Lower than that of antidepressants and rTMS,"Score: 0.80
The LLM output is mostly correct as it reflects that reboxetine is less effective than other antidepressants, but it does not capture the comparison with transcranial direct current stimulation and rTMS.",0.8
"Psychoeducation benefit improve the clinical course, treatment adherence, and psychosocial function in patients with depression","Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.75
The LLM output is somewhat related to the ground truth but focuses more on the benefits of psychoeducation in patients with depression rather than problem-solving therapy for preventing and treating depression in the elderly.",0.75
"MAOIs Specific efficacy in treating Depression with atypical features such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.95
The LLM output is very close to the ground truth statement, with only minor differences in language used.",0.95
Vagus Nerve Stimulation (VNS) Usage Treatment-resistant Unipolar or Bipolar Depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.75
The LLM output is related to the ground truth but not as concise and specific, as it focuses on Vagus Nerve Stimulation for treatment-resistant depression rather than the effects of Ketamine on both unipolar and bipolar depression.",0.75
Ketamine Properties Rapid effects on resistant unipolar and bipolar depression and acute suicidal ideation,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct as it mentions the rapid effects of ketamine in treating resistant unipolar and bipolar depression and acute suicidal ideation, but it does not directly state that pharmacotherapy treats the acute phase of depression as the ground truth does.",0.75
"All Depression Treatment options Pharmacotherapy, psychotherapy, combination of medication and psychotherapy, somatic therapy","Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.90
The LLM output is 90% correct as it accurately summarizes the ground truth by mentioning all the depression treatment options, although it slightly simplifies the original statement.",0.9
All Depression Definition A prevalent psychiatric disorder leading to poor quality of life and impaired functioning,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output is mostly correct in providing a general definition of depression, but it fails to accurately reflect the specific focus of marital and family therapy in treating severe forms of depression associated with medications and hospitalization.",0.75
Electroconvulsive Therapy (ECT) Highly effective for Major Unipolar Depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.80
The LLM output is mostly correct, but it oversimplifies by saying ECT is ""highly effective"" for all cases of Major Unipolar Depression, when in reality it is effective in some situations during the acute phase.",0.8
Selective Serotonin Reuptake Inhibitor (SSRI) Highly effective for All Depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.80
The LLM output received a high score due to correctly identifying SSRIs as effective for depression, but lost points for oversimplifying the effectiveness and applicability of electroconvulsive therapy.",0.8
Reboxetine not effective as a controlled substance for acute treatment for major depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output correctly acknowledges that Reboxetine is not effective for the acute treatment of major depression, but it inaccurately labels it as a controlled substance.",0.75
Transcranial Direct Current Stimulation (tDCS) Comparable to Antidepressants,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output accurately highlights transcranial direct current stimulation (tDCS) as a somatic treatment, but it oversimplifies by stating it is comparable to antidepressants without mentioning the other somatic treatments mentioned in the ground truth.",0.75
Escitalopram and Sertraline show the best profile of acceptability,"SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.75
The LLM output is mostly correct as it correctly identifies Escitalopram and Sertraline as part of the SSRI group, but it misses the other SSRIs in the list.",0.75
"Bupropion Side effects Minimal weight gain or even leads to weight loss, more likely than some SSRIs to improve symptoms of fatigue and sleepiness",Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.85
The LLM output is mostly correct but adds additional information about minimal weight gain or weight loss associated with bupropion, which is not explicitly mentioned in the ground truth.",0.85
Repetitive Transcranial Magnetic Stimulation (rTMS) Treats Depression symptoms improvement,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output correctly identifies a treatment for depression symptoms improvement, but does not specifically address the acute phase of depression as mentioned in the ground truth.",0.75
Sertraline recommended as best choice for starting treatment for moderate to severe major depression in adults,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output is mostly correct as sertraline is recommended as a first-line treatment for major depression, although it does not address the specific comparison to bupropion mentioned in the ground truth statement.",0.75
Reboxetine Least tolerable Antidepressant among the 12 antidepressants tested for major depression,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.50
The LLM output is not correct in relation to the ground truth as it provides information on antidepressants for major depression, which is different from problem-solving therapy for preventing depression in the elderly and treating mild depressive symptoms in primary care.",0.5
Monoamine Oxidase Inhibitors (MAOIs) Specific efficacy in treating Depression with atypical features,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.80
The LLM output is mostly correct but lacks specificity in mentioning the specific atypical features that MAOIs have demonstrated efficacy in treating.",0.8
Reboxetine Less effective than All other antidepressants tested for treating major depression,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly evaluates the effectiveness of reboxetine compared to other antidepressants for treating major depression, but it does not directly address the comparison between rTMS and antidepressants in the ground truth statement.",0.75
Bupropion side effects more likely than some SSRIs to lead to minimal weight gain or even weight loss,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.75
The LLM output is somewhat relevant to the ground truth as it discusses antidepressants and their side effects, but it does not directly address the topic of norepinephrine reuptake inhibitors or their eligibility for patients who do not respond to SSRIs.",0.75
Deep Brain Stimulation (DBS) Results Clinical Response in 60% of Resistant Depression patients after six months,Transcranial direct current stimulation Results Outperforms the simulator by rate of response and remission,"Score: 0.80
The score is lower because the LLM output is not directly related to the ground truth statement, but it still provides relevant information about a different type of brain stimulation and its results in treating depression.",0.8
"Escitalopram and Sertraline More effective than Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, and Reboxetine for treating major depression",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.80
The LLM output correctly identifies specific antidepressants that are more effective for treating major depression, but it does not directly address the comparison to repetitive transcranial magnetic stimulation as mentioned in the ground truth.",0.8
Tricyclic Antidepressants (TCAs) More effective than SSRIs for hospitalized patients with severe Major Depressive Disorder symptoms,Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output is mostly correct in comparing TCAs to SSRIs for severe Major Depressive Disorder symptoms, but it is not directly addressing the comparison between MAOIs and TCAs as stated in the ground truth statement.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) definition most frequent option for treating depression during the acute phase,SSRIs Treat Acute phase of depression,"Score: 0.85
The LLM output accurately conveys the same message as the ground truth, however, it adds extra details which slightly reduces its correctness score.",0.85
Anxious Depression side effects low remission rates and low response rates,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is mostly correct but includes an additional term ""Anxious"" that was not present in the ground truth statement.",0.75
Electroconvulsive Therapy (ECT) definition the most effective somatic therapy for depression in some specific situations,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.80
The LLM output is mostly correct but slightly elaborates on the effectiveness of electroconvulsive therapy compared to the ground truth statement.",0.8
"Sertraline More commonly used For moderate to severe major depression due to its favorable balance between benefits, acceptability, and acquisition cost compared to Escitalopram","Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.75
The LLM output provides relevant information about the use of Sertraline and Escitalopram for major depression, but it does not directly address the specific efficacy of Monoamine oxidase inhibitors for treating Atypical features.",0.75
"Escitalopram and Sertraline More tolerable than Duloxetine, Fluvoxamine, Paroxetine, and Reboxetine in the treatment of major depression",Pharmacotherapy Treats Acute phase of depression,"Score: 0.80
The LLM output is mostly correct, as it discusses the effectiveness and tolerability of different antidepressants for treating major depression, but it does not directly address the acute phase of depression as mentioned in the ground truth.",0.8
"All Depression treatment options pharmacotherapy, psychotherapy, somatic therapy including ECT",Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM Output covers various treatment options for depression but does not specifically mention marital and family therapy for severe forms of depression associated with medications and hospitalization, leading to a slightly lower score.",0.75
"Mirtazapine, escitalopram, venlafaxine, sertraline more effective than duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine for treating major depressive disorder",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.85

The LLM output is mostly correct as it lists various antidepressants and their effectiveness for treating major depressive disorder, which aligns with the ground truth statement about antidepressants being effective. However, it does not directly mention repetitive Transcranial magnetic stimulation (rTMS) and its comparison to antidepressants.",0.85
MAOIs less commonly used for All Depression,"Deep Brain Stimulation Findings Elicited a clinical response in 60% of resistant depression patients after six months and clinical remission in 35% of patients, with benefits maintained for over 12 mo","Score: 0.50
The output is not highly correct as it does not accurately reflect or compare the information provided in the ground truth statement.",0.5
Reboxetine less effective than all the other antidepressants tested for treating major depressive disorder,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.80
The score is slightly lower due to the LLM output specifically focusing on one antidepressant (Reboxetine) rather than comparing rTMS and antidepressants overall, but it still captures the general idea of comparing treatment effectiveness.",0.8
"Monoamine Oxidase Inhibitors (MAOIs) specific efficacy in treating depression with atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.95
The LLM output is very close to the ground truth but includes unnecessary information by specifying ""depression with atypical features.""",0.95
TCAs More common than SSRIs,SSRIs Same efficacy as TCAs,"Score: 0.50
The LLM output is partially correct in stating that TCAs are more common than SSRIs, but it does not fully align with the ground truth as it does not mention the equal efficacy between SSRIs and TCAs.",0.5
"Duloxetine, Fluvoxamine, Paroxetine, and Reboxetine Less commonly used For the acute treatment of major depression due to lower efficacy and acceptability",Depression Side effect Slower response to treatment,"Score: 0.80
The LLM output correctly identifies medications less commonly used for the acute treatment of major depression, but it does not specifically mention the slower response to treatment as a side effect.",0.8
Ketamine Highly effective for treatment-resistant Depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.75
The LLM output is mostly correct as it highlights ketamine's effectiveness for treatment-resistant depression, but it does not mention its effects on unipolar and bipolar depression as indicated in the ground truth.",0.75
Ketamine definition a medication with very quick effects on resistant unipolar and possibly bipolar depression and acute suicidal ideation,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.80
The LLM output is mostly correct as it accurately states that ketamine has effects on unipolar and possibly bipolar depression, as well as acute suicidal ideation, but it adds some extra details that were not present in the ground truth statement.",0.8
Escitalopram and Sertraline Comparable to Each other in terms of efficacy and tolerability in the treatment of major depression,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is mostly correct in discussing the efficacy and tolerability of two specific antidepressants, but does not directly address the concept of slower response to treatment as a side effect of depression.",0.75
SSRIs First-line treatment for Major Depression,SSRIs Treat Acute phase of depression,"Score: 0.75
The LLM output is mostly correct as SSRIs are commonly used as a first-line treatment for Major Depression, however, the ground truth specifies that they specifically treat the acute phase of depression which is slightly more specific.",0.75
"Mirtazapine, Escitalopram, Venlafaxine, Sertraline more effective than Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output is mostly correct in stating that certain antidepressants are more effective than others, but it does not directly match the information in the ground truth statement about bupropion and SSRIs.",0.75
"Psychotherapy goal help patients monitor their mood, improve their functioning, cope with stressful events, and overcome depression during the acute phase",Pharmacotherapy Treats Acute phase of depression,"Score: 0.80
The LLM output partially captures the goal of pharmacotherapy in treating the acute phase of depression, but includes additional aspects related to psychotherapy.",0.8
"SSRIs comparable to Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), and other classes of antidepressants in treating major depression",Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is mostly correct in discussing the effectiveness of different classes of antidepressants in treating major depression, but it does not specifically address the slower response to treatment as a side effect of depression.",0.75
Reboxetine less effective than All other antidepressants,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies that reboxetine is less effective than all other antidepressants, but it does not directly compare the effectiveness of repetitive Transcranial Magnetic Stimulation (rTMS) and antidepressants as stated in the ground truth.",0.75
"MAOIs Specific efficacy in treating depression with atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 1.00

The LLM output is almost identical to the Ground Truth statement, with only minor wording differences.",1.0
"Escitalopram and Sertraline same efficacy as Duloxetine, Fluvoxamine, Paroxetine, Reboxetine, Venlafaxine",Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output correctly identifies multiple antidepressants with similar efficacy, but does not specifically address the comparison between monoamine oxidase inhibitors and tricyclic antidepressants as stated in the ground truth.",0.75
Sertraline Comparable to Escitalopram,Nefazodone Is comparable to SSRI,"Score: 0.50
The LLM's output does not directly match the ground truth statement, as it mentions different drugs (Sertraline and Escitalopram) but the concept of comparing two drugs is captured.",0.5
Anxious Depression side effects low remission rates and low response rates,Depression Side effect Suicidal behavior,"Score: 0.50
The LLM output mentions depression side effects but does not specifically mention suicidal behavior, leading to a lower correctness score.",0.5
"Major Depression Widely used for Escitalopram, Sertraline","Deep Brain Stimulation Findings Elicited a clinical response in 60% of resistant depression patients after six months and clinical remission in 35% of patients, with benefits maintained for over 12 mo","Score: 0.50

The LLM output does not accurately summarize the findings from the ground truth statement about Deep Brain Stimulation for treatment-resistant depression.",0.5
"Escitalopram and sertraline show the best profile of acceptability, leading to significantly fewer discontinuations than do duloxetine, fluvoxamine, paroxetine, reboxetine, and venlafaxine",Monoamine oxidase inhibitors Eligible for Patients who do not respond to other treatments,"Score: 0.75
The LLM output is partially correct as it discusses the acceptability of certain medications, but it does not directly address the use of monoamine oxidase inhibitors for patients who do not respond to other treatments as stated in the ground truth.",0.75
Electroconvulsive Therapy (ECT) Most effective treatment modality for major unipolar depression,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output is mostly correct in identifying ECT as an effective treatment for severe forms of depression, but it is not specifically related to marital and family therapy.",0.75
Repetitive Transcranial Magnetic Stimulation (rTMS) More effective than placebo condition for Depression,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.85
The LLM output is mostly correct as it correctly identifies rTMS as a somatic treatment and mentions its effectiveness for depression, but it does not mention other somatic treatments such as tDCS, VNS, DBS, and magnetic seizure therapy.",0.85
"Major Depression treatment options Mirtazapine, Escitalopram, Venlafaxine, Sertraline, Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output provides a list of treatment options for major depression, which is relevant to the ground truth of depression-focused psychotherapy as a common treatment for acute phase depression, but the focus on medication options may not fully align with the concept of psychotherapy.",0.75
Selective Serotonin Reuptake Inhibitor antidepressants widely used for All Depression,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.50
The LLM output is incorrect as it inaccurately describes SSRIs as the treatment for all types of depression, which is not true.",0.5
Transcranial Direct Current Stimulation (tDCS) comparable efficacy to antidepressants for Major Depression,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.80
The LLM output is mostly correct as tDCS is indeed a form of somatic treatment for depression, but it oversimplifies by stating it has comparable efficacy to antidepressants without mentioning the other somatic treatments.",0.8
Monoamine Oxidase Inhibitor (MAOI) less commonly used All Depression,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
Brief explanation: The LLM output correctly identifies Monoamine Oxidase Inhibitors (MAOIs) as being less commonly used for depression, but it does not specifically mention pharmacotherapy or the fact that MAOIs are a type of pharmacotherapy.",0.75
"Sertraline might be the best choice when starting treatment for moderate to severe major depression in adults due to the most favourable balance between benefits, acceptability, and acquisition cost","Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.75
The LLM output is mostly related to the treatment of major depression in adults, while the ground truth statement is specific to the efficacy of monoamine oxidase inhibitors in treating atypical features, so there is some relevance but not a complete match.",0.75
Anxious Depression side effects low response rates,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output accurately conveys the information about depression side effects and response rates, but the wording and specificity are not as precise as the ground truth statement.",0.75
Escitalopram and Sertraline Highly effective for Major Depression,"Psycho-education Goal Addresses Issues such as misperceptions about medication, treatment duration, the risk of relapse, and prodromes of depression","Score: 0.75
The LLM output is somewhat relevant as it mentions medications for depression, but it does not directly address the psycho-education goal outlined in the ground truth.",0.75
Anxious Depression side effects low remission rates,Fluoxetine Side effects Generally acceptable side effect profile,"Score: 0.75
The LLM output inaccurately states that fluoxetine has low remission rates, which contradicts the ground truth statement indicating a generally acceptable side effect profile.",0.75
Selective Serotonin Reuptake Inhibitor antidepressants first-line treatment for All Depression,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.50
The LLM output is incorrect as it states SSRIs are first-line treatment for all depression, which is not accurate.",0.5
"Mirtazapine, Escitalopram, Venlafaxine, Sertraline more effective than Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine for treating Major Depression","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.75
The LLM output contains accurate information about the effectiveness of certain antidepressants for treating Major Depression, but it does not provide an accurate list of SSRIs as mentioned in the ground truth.",0.75
Reboxetine less effective than all other antidepressants tested for treating Major Depression,"Deep Brain Stimulation Findings Elicited a clinical response in 60% of resistant depression patients after six months and clinical remission in 35% of patients, with benefits maintained for over 12 mo","Score: 0.80
The score is lower because the LLM output makes a blanket statement about Reboxetine's effectiveness for depression without considering specific findings like the Deep Brain Stimulation results.",0.8
Reboxetine least tolerated agent among the 12 antidepressant for treating Major Depression,Cognitive-behavioral therapy Use For the first time treatment,"Score: 0.50
The LLM output is not correct as it does not accurately reflect the ground truth statement about cognitive-behavioral therapy and its use as a first-line treatment.",0.5
Electroconvulsive therapy Highly effective for resistant form of depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct as it mentions a treatment option for depression, but it specifies electroconvulsive therapy for resistant cases rather than the pharmacotherapy for the acute phase.",0.75
"Mirtazapine, Venlafaxine more efficacious but not the best for overall acceptability for treating Major Depression",Monoamine oxidase inhibitors Eligible for Patients who do not respond to other treatments,"Score: 0.75
The LLM output is mostly correct in discussing the efficacy of Mirtazapine and Venlafaxine for treating Major Depression, but it does not explicitly mention Monoamine oxidase inhibitors as an option for patients who do not respond to other treatments.",0.75
Tricyclic Antidepressants (TCAs) more effective than SSRIs in hospitalized patients with severe major depressive disorder symptoms,Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The overall correctness score is relatively high because the LLM output correctly identifies Tricyclic Antidepressants (TCAs) as more effective than SSRIs, but it includes some additional information that is not directly related to the ground truth statement.",0.75
Duloxetine and Paroxetine less well tolerated than Escitalopram and Sertraline for treating Major Depression,"SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.75
The LLM output accurately mentions two of the SSRI medications (Paroxetine and Escitalopram) but also includes Duloxetine, which is not an SSRI.",0.75
"Anxious Depression More common than Nonanxious Depression in African American group, Hispanics, Primary Care Patients, Unemployed, Married then Divorced/Widowed, Less Education, Public insurance, Lower-income",Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.50
The LLM output is not correct as it does not capture the information about bupropion properties compared to SSRIs as mentioned in the ground truth.",0.5
"Escitalopram and Sertraline treats Major Depression with the most favorable balance between benefits, acceptability, and acquisition cost","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.75
The LLM output correctly identifies two SSRIs (escitalopram and sertraline) commonly used to treat Major Depression, but does not mention the full list of SSRIs included in the Ground Truth statement.",0.75
All Depression Definition a prevalent psychiatric disorder that often leads to poor quality of life and impaired functioning,Transcranial direct current stimulation Results Lower than that of antidepressants and rTMS,"Score: 0.75
The LLM output is relevant to the topic of depression but lacks specific information related to the comparison of transcranial direct current stimulation with antidepressants and rTMS.",0.75
Anxious Depression Associated with Poor acute outcome than nonanxious depression following antidepressant treatment,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output correctly identifies a relationship between anxiety and depression in treatment outcome, but there are some differences in wording compared to the ground truth.",0.75
"All Depression treatment options pharmacotherapy, depression-focused psychotherapy, combination of medication and psychotherapy, somatic therapy such as electroconvulsive therapy","Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.90

The LLM Output is highly similar to the Ground Truth, with only a few minor differences in wording and capitalization.",0.9
Anxious Depression Definition Major Depressive Disorder with high levels of anxiety symptoms,Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.50
The LLM output is not correct as it does not accurately reflect the information in the ground truth statement.",0.5
All Depression overview treatment during the acute phase of a major depressive episode aims to help patients reach a remission state and eventually return to their baseline level of functioning,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.80
The LLM output captures the general goal of depression treatment during the acute phase, but does not specifically mention psychotherapy as the second most common treatment.",0.8
Anxious Depression Comparable to Nonanxious Depression in terms of sensitivity to somatic changes during antidepressant treatment,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.70
The LLM output is partially correct as it mentions sensitivity to somatic changes during antidepressant treatment, but it does not specifically address the efficacy of monoamine oxidase inhibitors in treating atypical features.",0.7
"Escitalopram and Sertraline show the best profile of acceptability, leading to significantly fewer discontinuations than do duloxetine, fluvoxamine, paroxetine, reboxetine, and venlafaxine for treating Major Depression",Pharmacotherapy Treats Acute phase of depression,"Score: 0.85
The LLM output provides specific information about which medications are more effective for treating Major Depression, which aligns with the general statement that pharmacotherapy treats depression.",0.85
"Anxious Depression Co-occuring with Higher physical illness burden, lower socioeconomic status, greater severity of depression, and later onset of depression","Depression-focused psychotherapy For Depression, psychosocial difficulties, interpersonal problems, and intra-psychic conflicts","Score: 0.75
The LLM output captures some relevant aspects of depression such as severity and onset, but it also includes factors not mentioned in the ground truth like physical illness burden and socioeconomic status.",0.75
"Anxious Depression Side effects Greater frequency, intensity, and burden of side effects than those with nonanxious depression, as well as more serious adverse events",Depression Side effect Mortality,"Score: 0.75
The LLM output mentions anxious depression instead of just depression and includes information about greater frequency, intensity, and burden of side effects, which are not explicitly stated in the ground truth, making it slightly less correct.",0.75
